Clifford Swan Investment Counsel LLC Has $23.84 Million Stock Position in Procter & Gamble Company (The) $PG

Clifford Swan Investment Counsel LLC cut its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 1.3% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 149,644 shares of the company’s stock after selling 1,932 shares during the period. Clifford Swan Investment Counsel LLC’s holdings in Procter & Gamble were worth $23,841,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently made changes to their positions in PG. Nova Wealth Management Inc. bought a new stake in Procter & Gamble during the first quarter worth $26,000. Signature Resources Capital Management LLC increased its stake in shares of Procter & Gamble by 67.9% during the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after purchasing an additional 72 shares during the last quarter. Quarry LP bought a new stake in shares of Procter & Gamble in the 1st quarter valued at about $33,000. Mid American Wealth Advisory Group Inc. acquired a new stake in Procter & Gamble in the 2nd quarter valued at about $34,000. Finally, RMG Wealth Management LLC bought a new position in Procter & Gamble during the second quarter worth about $37,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

NYSE PG opened at $152.12 on Thursday. Procter & Gamble Company has a 12-month low of $146.96 and a 12-month high of $180.43. The firm has a 50-day moving average price of $154.73 and a two-hundred day moving average price of $158.50. The company has a market capitalization of $356.03 billion, a P/E ratio of 23.37, a P/E/G ratio of 4.02 and a beta of 0.36. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business had revenue of $20.89 billion during the quarter, compared to analysts’ expectations of $20.79 billion. During the same period in the previous year, the company posted $1.40 earnings per share. The firm’s revenue for the quarter was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be given a $1.0568 dividend. The ex-dividend date is Friday, October 24th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. Procter & Gamble’s dividend payout ratio (DPR) is presently 64.98%.

Wall Street Analysts Forecast Growth

PG has been the topic of several research analyst reports. Evercore ISI restated an “in-line” rating and issued a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. UBS Group decreased their target price on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. Bank of America dropped their price target on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Barclays dropped their price objective on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. Finally, BNP Paribas Exane lowered their price target on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a report on Tuesday, September 23rd. Eleven investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $171.68.

Insiders Place Their Bets

In other news, CFO Andre Schulten sold 11,638 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the completion of the sale, the chief financial officer owned 52,642 shares of the company’s stock, valued at approximately $8,279,007.34. This represents a 18.11% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Marc S. Pritchard sold 9,849 shares of the firm’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,548,952.23. Following the completion of the sale, the insider directly owned 182,422 shares in the company, valued at approximately $28,689,507.94. This represents a 5.12% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 149,763 shares of company stock valued at $23,421,279 over the last 90 days. 0.20% of the stock is owned by company insiders.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.